Thousands of investors, millions in profit
Results 1 - 10 of 726 : 1 2 3 4 5 6 7 8 9 Next
5 Pharmaceutical Stocks With Significant Exposure to Europe
A fracture of the European monetary union could spell trouble for these five pharmaceutical stocks.
Can Dendreon's New Management Turn Things Around?
It's too early to tell.
Rheumatoid arthritis drug tofacitinib could be a blockbuster.
How Workers Blew Their Best Chance to Retire Rich
In an amazing three-year period, 401(k) balances didn't rise nearly as much as they should have.
1 Unexcitingly Good Dividend Play
Merck has slow growth, but that's OK.
Why Dividend Stocks Aren't a Screaming Deal
Low bond yields make dividends look good, but is it a return to historical norms?
Drug cocktails are the future of hepatitis C drugs.
You'll Have to Hold This One for the Dividend
Not many other reasons to hold J&J in the short term right now.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK